Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB
WHITEHEAD INSTITUTE FOR
BIOMEDICAL RESEARCH, ORDER:
13 Plaintiffs, (1) GRANTING PLAINTIFFS’ 14 v. MOTIONS TO FILE DOCUMENTS UNDER SEAL; AND SHORELINE BIOSCIENCES, INC.; and
DAN S. KAUFMAN, [Doc. Nos. 75, 109.] Defendants. (2) DIRECTING THE CLERK TO
FILE THE PROPOSED
DOCUMENTS UNDER SEAL
20 [Doc. Nos. 39, 110.] 21 On July 7, 2022, Defendant Dan S. Kaufman filed an answer and counterclaims. 22 (Doc. No. 39.) On October 25, 2022, Plaintiffs Fate Therapeutics, Inc. (“Fate”) and 23 Whitehead Institute of Biomedical Research (“Whitehead”) filed a motion to seal portions 24 of Defendant Kaufman’s answer and counterclaims pursuant to Civil Local Rule 79.2 and 25 Patent Local Rule 2.2. (Doc. No. 75.) Defendant Kaufman does not oppose Plaintiffs’ 26 October 25, 2022 motion to seal. (See Doc. No. 75-1, Scaccia Decl. ¶ 6.) On…